Balyasny Asset Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Balyasny Asset Management's EXAS Position: Q1 2026 in Review
Balyasny Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 4,089,977 shares — an estimated $415M sold.
Balyasny Asset Management first reported a position in EXAS in Q4 2015 and held it in 23 quarters. The position peaked at $415M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Balyasny Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Balyasny Asset Management sold 4,089,977 Exact Sciences shares in Q1 2026, an estimated $415M.
- Balyasny Asset Management first reported a position in Exact Sciences in Q4 2015 and held it in 23 quarters.
- Balyasny Asset Management's Exact Sciences position peaked at $415M in Q4 2025.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.